These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28185617)

  • 1. Mycobacterium kansasii.
    Johnston JC; Chiang L; Elwood K
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium kansasii pulmonary diseases in Korea.
    Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
    J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
    Saleem N; Saba R; Maddika S; Weinstein M
    Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium kansasii and human immunodeficiency virus co-infection in London.
    Klein JL; Corbett EL; Slade PM; Miller RF; Coker RJ
    J Infect; 1998 Nov; 37(3):252-9. PubMed ID: 9892529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin-resistant Mycobacterium kansasii.
    Wallace RJ; Dunbar D; Brown BA; Onyi G; Dunlap R; Ahn CH; Murphy DT
    Clin Infect Dis; 1994 May; 18(5):736-43. PubMed ID: 8075262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary
    Padmapriyadarsini C; Nair D; Gomathi NS; Velayudham B
    Indian J Med Microbiol; 2016; 34(4):516-519. PubMed ID: 27934834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.
    Han SH; Kim KM; Chin BS; Choi SH; Lee HS; Kim MS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Kim JM
    J Korean Med Sci; 2010 Feb; 25(2):304-8. PubMed ID: 20119588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.
    Lovell JP; Zerbe CS; Olivier KN; Claypool RJ; Frein C; Anderson VL; Freeman AF; Holland SM
    Ann Am Thorac Soc; 2016 Dec; 13(12):2169-2173. PubMed ID: 27607353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.
    Evans SA; Colville A; Evans AJ; Crisp AJ; Johnston ID
    Thorax; 1996 Dec; 51(12):1248-52. PubMed ID: 8994524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
    Mori M; Ageshio F; Kagawa H; Oshitani Y; Fujikawa T; Saito H; Sako H; Yano Y; Kitada S; Maekura R
    Kekkaku; 2015 Aug; 90(8):619-23. PubMed ID: 26665518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and epidemiological characteristics of M. kansasii pulmonary infections from Rio de Janeiro, Brazil, between 2006 and 2016.
    Goldenberg T; Gayoso R; Mogami R; Lourenço MC; Ramos JP; Carvalho LD; Dalcolmo MP; Mello FCQ
    J Bras Pneumol; 2020; 46(6):e20190345. PubMed ID: 32696934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
    Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC
    J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
    Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
    Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
    Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
    Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
    Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.
    Guo Y; Cao Y; Liu H; Yang J; Wang W; Wang B; Li M; Yu F
    Microbiol Spectr; 2022 Feb; 10(1):e0147521. PubMed ID: 35019778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
    Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
    Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
    Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
    Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.